Chemical and Biological Defense Program - Office of the Under ...

UNCLASSIFIED
Exhibit P-5, Cost Analysis: PB 2014 Chemical and Biological Defense Program Date: April 2013
Appropriation / Budget Activity / Budget Sub Activity:
0300D: Procurement, Defense-Wide / BA 03: Chemical/
Biological Defense / BSA 1: CBDP
P-1 Line Item Nomenclature:
MA0800 - JOINT BIO DEFENSE PROGRAM (MEDICAL)
Resource Summary Prior Years FY 2012 FY 2013 #
LI MA0800 - JOINT BIO DEFENSE PROGRAM (MEDICAL) UNCLASSIFIED
Chemical and Biological Defense Program Page 13 of 17 P-1 Line #92
Item Nomenclature (Item Number - Item
Name, DODIC):
JX0005 - DOD BIOLOGICAL VACCINE
PROCUREMENT
FY 2014 Base FY 2014 OCO ##
FY 2014 Total
Procurement Quantity (Units in Each) - - - - - -
Gross/Weapon System Cost ($ in Millions) 610.091 0.180 0.185 0.185 - 0.185
Less PY Advance Procurement ($ in Millions) - - - - - -
Net Procurement (P1) ($ in Millions) 610.091 0.180 0.185 0.185 - 0.185
Plus CY Advance Procurement ($ in Millions) - - - - - -
Total Obligation Authority ($ in Millions) 610.091 0.180 0.185 0.185 - 0.185
(The following Resource Summary rows are for informational purposes only. The corresponding budget requests are documented elsewhere.)
Initial Spares ($ in Millions) - - - - - -
Gross/Weapon System Unit Cost (Units in Thousands) - - - - - -
# FY 2013 Program is from the FY 2013 President's Budget, submitted February 2012
## The FY 2014 OCO Request will be submitted at a later date
Cost Elements
(† indicates the
presence of a P-5A)
PackageFielding Cost
Recurring Cost
Vaccinia Immune
Globulin-Support
Costs
ID Unit Cost
CD ($ K )
All Prior Years FY 2012 FY 2013 FY 2014 Base FY 2014 OCO FY 2014 Total
Quantity
(Each)
Total
Cost
($ M )
Unit Cost
($ K )
Quantity
(Each)
Total
Cost
($ M )
Unit Cost
($ K )
Quantity
(Each)
Total
Cost
($ M )
Unit Cost
($ K )
- - 0.360 - - 0.180 - - 0.185 - - 0.185 - - - - - 0.185
Total Recurring Cost 0.360 0.180 0.185 0.185 - 0.185
Total Package Fielding Cost 0.360 0.180 0.185 0.185 - 0.185
Gross Weapon System
Cost
Quantity
(Each)
Total
Cost
($ M )
Unit Cost
($ K )
Quantity
(Each)
Total
Cost
($ M )
Unit Cost
($ K )
610.091 0.180 0.185 0.185 - 0.185
P-5 Remarks:
The biological vaccine procurement program is critical for national defense. These products directly support the Secretary of Defense program to maintain a DoD capability to acquire and stockpile adequate
quantities of all BW vaccines to protect the programmed force against validated biological warfare (BW) agents. Items currently in the stockpile are the FDA licensed Anthrax Vaccine Adsorbed (AVA), Smallpox
vaccine, and Vaccinia Immune Globulin Intravenous (VIGIV). Funding supports vaccine and licensed biologic production, quality assurance and control, process, equipment validation, process change
management, documentation control, and all FDA license maintenance and post-approval commitments (Phase 4 clinical trials). The annual vaccination program for the Services is funded by the Defense
Health Program.
Justification: FY14 funds procure the biologic VIGIV support for shipping costs associated with emergency use product.
Quantity
(Each)
Total
Cost
($ M )
59